Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibi... von Olgun, Polat, Diker, Omer

Volltext

Pre-treatment pan-immune-inflammation value (PIV) and pile prognostic score in patients treated with immunotherapy von Olgun, Polat, Diker, Omer

Volltext

Optic atrophy after cabazitaxel treatment in a patient with castration-resistant prostate cancer: a case report von Diker, Sevda, Diker, Ömer

Volltext

Ibrutinib Regimens in Older Patients with Untreated CLL von Diker, Omer, Sengar, Manju, Gogtay, Nithya, Jain, Hasmukh, Mercier, Toine, Janssens, Ann, Maertens, Johan, Woyach, Jennifer A, Ruppert, Amy S, Mandrekar, Sumithra J

Volltext

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer von Diker, Omer

Volltext

Development of a Novel Predictive-Prognostic Scoring Index for Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer von Diker, Omer, Olgun, Polat, Balyemez, Ugurcan, Sigit Ikiz, Sinem

Volltext

The role of the pharmacist in improving medication beliefs and adherence in cancer patients von Birand, Nevzat, Boşnak, Ahmet Sami, Diker, Ömer, Abdikarim, Abdi, Başgut, Bilgen

Volltext

A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey von Boga, Ibrahim, Ozemri Sag, Sebnem, Duman, Nilgun, Ozdemir, Sevda Yesim, Ergoren, Mahmut Cerkez, Dalci, Kubilay, Mujde, Cem, Parsak, Cem Kaan, Rencuzogullari, Cagla, Sonmezler, Ozge, Yalav, Orcun, Alemdar, Adem, Aliyeva, Lamiya, Bozkurt, Ozlem, Cetintas, Sibel, Cubukcu, Erdem, Deligonul, Adem, Dogan, Berkcan, Ornek Erguzeloglu, Cemre, Evrensel, Turkkan, Gokgoz, Sehsuvar, Senol, Kazim, Tolunay, Sahsine, Akyurek, Esra, Basgoz, Neslihan, Gökçe, Nuriye, Dundar, Bilge, Ozturk, Figen, Taskin, Duygu, Demirtas, Mercan, Cag, Murat, Diker, Omer, Olgun, Polat, Tug Bozdogan, Sevcan, Dundar, Munis, Bisgin, Atil, Temel, Sehime Gulsun

Volltext

The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy von Boşnak, Ahmet S, Birand, Nevzat, Diker, Ömer, Abdi, Abdikarim, Başgut, Bilgen

Volltext

First-line pembrolizumab efficacy in patients with advanced non-small cell lung cancer: A Bi-center retrospective, real-life experience study von Diker, Omer, Olgun, Polat

Volltext

Real-World Data of Nivolumab and Pembrolizumab in Platinum Refractory Advanced Non-Small Cell Lung Cancer: Potential Practical Predictors of Treatment von DIKER, OMER

Volltext

Pembrolizumab plus Chemotherapy in Lung Cancer von Diker, Omer

Volltext

Pembrolizumab plus Chemotherapy in Lung Cancer von Gil-Sierra, Manuel D, Fenix-Caballero, Silvia, Alegre-del Rey, Emilio J, Sun, Ryan, Rich, Michael W, Wei, Lee-Jen, Diker, Omer, Gandhi, Leena, Garassino, Marina C

Volltext

Should every adult patient in the hospital have an internist? von Tanriover, Mine Durusu, Guven, Goksel, Buldukoglu, Cagin, Diker, Omer, Halacli, Burcin, Yildirim, Gonul, Topeli, Arzu

Volltext

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer von Weiss, Glen J, Addeo, Alfredo, Diker, Omer, Horn, Leora, Liu, Stephen V

Volltext

When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis von Karakas, Yusuf, Vural, Secil, Diker, Omer, Dizdar, Omer

Volltext

Abstract PS10-52: Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience von Diker, Omer, Aktas, Burak Yasin, Ak, Recep, Koylu, Bahadir, Bas, Onur, Olgun, Polat, Taban, Hakan, Guven, Deniz Can, Kertmen, Neyran, Oksuzoglu, Berna, Aksoy, Sercan

Volltext

Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience von Diker, Omer, Aktas, Burak Yasin, Ak, Recep, Koylu, Bahadir, Bas, Onur, Taban, Hakan, Guven, Deniz Can, Olgun, Polat, Kertmen, Neyran, Dizdar, Omer, Oksuzoglu, Berna, Aksoy, Sercan

Volltext

Lung Cancer with a High Tumor Mutational Burden von VanderLaan, Paul A, Rangachari, Deepa, Costa, Daniel B, Hellmann, Matthew D, Paz-Ares, Luis

Volltext

Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Grou... von Akyildiz, Arif, Guven, Deniz Can, Koksal, Baris, Karaoglan, Beliz Bahar, Kivrak, Derya, Ismayilov, Rashad, Aslan, Firat, Sutcuoglu, Osman, Yazici, Ozan, Kadioglu, Ahmet, Alan, Ozkan, Majidova, Nargiz, Erciyestepe, Mert, Ozcan, Erkan, Akdag, Goncagul, Taban, Hakan, Kaya, Ali Osman, Guliyev, Murad, Yildirim, Nilgun, Sakalar, Teoman, Yazilitas, Dogan, Unal, Caglar, On, Sercan, Biter, Sedat, Demirci, Nebi Serkan, Senler, Filiz Cay, Kemal, Yasemin, Halil, Omer Diker, Gullu, Ibrahim, Aksoy, Sercan

Volltext